CMS Launches Medicare GLP-1 Bridge Program to Improve Access
CMS has introduced the **Medicare GLP-1 Bridge** program to provide access to select GLP-1 medications for **$50 per month** for eligible beneficiaries through **December 31, 2027**. This innovative initiative aims to enhance weight management treatment and could influence future procurement opportunities within the pharmaceutical industry, especially concerning Medicare Part D.